INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
PM
Pelkowski Julie MarieEVP & CFO
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$3,044
12 sh
Apr 21, 2026Apr 22, 2026
Page 921 of 1737
← PrevNext →
traded Apr 21, 2026
+1d
SEC Form 4

Evidence

12
BS
Boughton SoleilChief Legal Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$284K
9,463 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

12
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M$177K
5,235 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
SP
Srinivasa ParthasarathyEVP, Chief Information Officer
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$2,812
11 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
NL
Novacek Jorie LSVP, Controller
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$1,151
5 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

11
HJ
Hogan Michael JamesChief Business Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$30K
500 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

11
DN
Debbi NirDirector, President
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$273
8 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

10
FA
Fang AndyDirector
DASHDoorDash, Inc.
Grant or award
A—
11.2K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

10
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
738 sh
Apr 22, 2026Apr 22, 2026
traded Apr 22, 2026
+0dSEC Form 4

Evidence

10
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Grant or award
A—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JR
Jain RitaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
6,030 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
MA
Martin John ArthurChief Financial Officer
GSHDGoosehead Insurance, Inc.
Grant or award
A—
40.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
LF
Lizzul Paul F.Chief Medical Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
6,145 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
LF
Lizzul Paul F.Chief Medical Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
70.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
LF
Lizzul Paul F.Chief Medical Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
83.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
GN
Gomez Aidan N.Director
RIVNRivian Automotive, Inc. / DE
Grant or award
A—
810 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
OJ
O'Connor James JosephChief Business Officer and GC
NERVMinerva Neurosciences, Inc.
Grant or award
A—
350.8K sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

9
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Option exercise
M—
162 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JR
Jain RitaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
10.6K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
OA
Oleas Jurg AmadeoDirector
AMRZAmrize Ltd
Tax withholding
F$8,968
157 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
SH
Schwartz Sanford HaroldDirector
RIVNRivian Automotive, Inc. / DE
Grant or award
A—
1,255 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
CK
Chainey KimberlyDirector
HCCWARRIOR MET COAL, INC.
Grant or award
A—
1,423 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
98.6K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
6,030 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
6,030 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
9,200 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
16.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JR
Jain RitaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
1,300 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JR
Jain RitaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
5,500 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JR
Jain RitaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
8,015 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
GN
Gomez Aidan N.Director
RIVNRivian Automotive, Inc. / DE
Tax withholding
F$6,995
406 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
5,500 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
OA
Otitoju Kolawole A.Chief Bus. & Strategy Officer
MASS908 Devices Inc.
Grant or award
A—
110.2K sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
16.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
CN
Cox Erin NealyDirector
SBHSally Beauty Holdings, Inc.
Option exercise
M—
14.5K sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

9
WC
Whitman Margaret CDirector
CRWVCoreWeave, Inc.
Grant or award
A$7,829
67 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
4,000 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
LK
Low Check KianDirector
AVGOBroadcom Inc.
Tax withholding
F$47K
117 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
SB
Shardelow Bianca B.VP, Controller & CAO
CXTCrane NXT, Co.
Tax withholding
F$8,445
182 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence